BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31158410)

  • 1. Active fusions of Cas9 orthologs.
    Josipović G; Zoldoš V; Vojta A
    J Biotechnol; 2019 Aug; 301():18-23. PubMed ID: 31158410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
    Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
    Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
    Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
    Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 Facilitated Multiple-Chromosome Fusion in Saccharomyces cerevisiae.
    Shao Y; Lu N; Qin Z; Xue X
    ACS Synth Biol; 2018 Nov; 7(11):2706-2708. PubMed ID: 30352154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9.
    Feng Y; Chen C; Han Y; Chen Z; Lu X; Liang F; Li S; Qin W; Lin S
    G3 (Bethesda); 2016 Aug; 6(8):2517-21. PubMed ID: 27317783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
    Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
    Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing targeted DNA methylation and demethylation using dCas9.
    Pflueger C; Swain T; Lister R
    Essays Biochem; 2019 Dec; 63(6):813-825. PubMed ID: 31724704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
    Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
    Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
    Hu X; Meng X; Liu Q; Li J; Wang K
    Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific recruitment of epigenetic factors with a modular CRISPR/Cas system.
    Anton T; Bultmann S
    Nucleus; 2017 May; 8(3):279-286. PubMed ID: 28448738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
    Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
    Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editing of DNA Methylation Patterns Using CRISPR-Based Tools.
    Smith J; Banerjee R; Weeks RJ; Chatterjee A
    Methods Mol Biol; 2022; 2458():63-74. PubMed ID: 35103962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine.
    Huang W; Zeng ZC; Wang WT; Sun YM; Chen YQ; Luo XQ; Fang K
    Clin Transl Med; 2021 Mar; 11(3):e355. PubMed ID: 33783997
    [No Abstract]   [Full Text] [Related]  

  • 18. Allele-specific genome editing of imprinting genes by preferentially targeting non-methylated loci using Staphylococcus aureus Cas9 (SaCas9).
    Liu Y; Li J; Zhou C; Meng B; Wei Y; Yang G; Lu Z; Shen Q; Zhang Y; Yang H; Qiao Y
    Sci Bull (Beijing); 2019 Nov; 64(21):1592-1600. PubMed ID: 36659571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application.
    Minkenberg B; Wheatley M; Yang Y
    Prog Mol Biol Transl Sci; 2017; 149():111-132. PubMed ID: 28712493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond Native Cas9: Manipulating Genomic Information and Function.
    Mitsunobu H; Teramoto J; Nishida K; Kondo A
    Trends Biotechnol; 2017 Oct; 35(10):983-996. PubMed ID: 28739220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.